EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review

Flavia Bigi, Enrica Manzato, Simona Barbato iD, Marco Talarico, Michele Puppi, Simone Masci, Ilaria Sacchetti, Roberta Restuccia, Miriam Iezza, Ilaria Rizzello iD, Chiara Sartor iD, Katia Mancuso iD und 4 weitere

Pharmaceuticals · 15.07.2024 · 17 (7) · 944

DOI: 10.3390/ph17070944 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 15.07.2024. Verfasst von Flavia Bigi und 15 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", 40138 Bologna, Italy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della salute, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This systematic review examines the available clinical data on CD34+ cell mobilization, collection, and engraftment in multiple myeloma patients treated with the anti-CD38 monoclonal antibodies daratumumab and isatuximab in clinical trials and in real life. Twenty-six clinical reports were published between 2019 and February 2024. Most studies documented lower circulating CD34+ cells after mobilization compared to controls, leading to higher plerixafor requirements. Although collection yields were significantly lower in approximately half of the studies, the collection target was achieved in similar proportions of daratumumab- and isatuximab-treated and nontreated patients, and access to autologous stem cell transplant (ASCT) was comparable. This could be explained by the retained efficacy of plerixafor in anti-CD38 monoclonal antibody-treated patients, while no chemotherapy-based or sparing mobilization protocol proved superior. Half of the studies reported slower hematopoietic reconstitution after ASCT in daratumumab- and isatuximab-treated patients, without an excess of infectious complications. While no direct effect on stem cells was observed in vitro, emerging evidence suggests possible dysregulation of CD34+ cell adhesion after daratumumab treatment. Overall, anti-CD38 monoclonal antibodies appear to interfere with CD34+ cell mobilization, without consistently leading to significant clinical consequences. Further research is needed to elucidate the underlying mechanisms and define optimal mobilization strategies in this patient population.

Schlagwörter

Stichwörter der Autor:innen

autologous stem cell transplantcollectiondaratumumabhematopoietic stem cellsisatuximabmobilizationmultiple myelomaplerixafor

Autor:innen und Institutionen

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", 40138 Bologna, Italy.
  • Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, 40138 Bologna, Italy.

ORCID-Profile: Simona Barbato, Ilaria Rizzello, Chiara Sartor, Katia Mancuso, Paola Tacchetti, Michele Cavo, Elena Zamagni

Förderung

  • Ministero della salute
  • Italian Ministry of Health

Zitieren

APA

Bigi, F., Manzato, E., Barbato, S., Talarico, M., Puppi, M., Masci, S., Sacchetti, I., Restuccia, R., Iezza, M., Rizzello, I., Sartor, C., Mancuso, K., Pantani, L., Tacchetti, P., Cavo, M., & Zamagni, E. (2024). Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review. Pharmaceuticals, 17(7), 944. https://doi.org/10.3390/ph17070944

Vancouver

Bigi F, Manzato E, Barbato S, Talarico M, Puppi M, Masci S, et al. Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review. Pharmaceuticals. 2024;17(7):944. doi:10.3390/ph17070944

BibTeX
@article{Bigi2024,
  author = {Bigi, Flavia and Manzato, Enrica and Barbato, Simona and Talarico, Marco and Puppi, Michele and Masci, Simone and Sacchetti, Ilaria and Restuccia, Roberta and Iezza, Miriam and Rizzello, Ilaria and Sartor, Chiara and Mancuso, Katia and Pantani, Lucia and Tacchetti, Paola and Cavo, Michele and Zamagni, Elena},
  title = {Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {7},
  pages = {944},
  doi = {10.3390/ph17070944}
}
Kostenlos starten →